Views for Preservation HIV-1–specific IFNg+ CD4+ T-Cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial.
Total visits
views | |
---|---|
Preservation HIV-1–specific IFNg+ CD4+ T-Cell responses in breakthrough infections after exposure to tenofovir gel in the CAPRISA 004 microbicide trial. | 299 |
Total visits per month
views | |
---|---|
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
File Visits
views | |
---|---|
Mureithi_Marianne_W_2011.pdf | 221 |
Mureithi_Marianne_W_2011.pdf(legacy) | 32 |
Top country views
views | |
---|---|
United States | 121 |
South Africa | 48 |
Sweden | 25 |
Germany | 20 |
Netherlands | 12 |
Vietnam | 9 |
Ireland | 8 |
Moldova | 8 |
France | 7 |
China | 6 |
Russia | 5 |
Finland | 4 |
Singapore | 4 |
India | 2 |
Austria | 1 |
Canada | 1 |
United Kingdom | 1 |
Greece | 1 |
Iraq | 1 |
South Korea | 1 |
Top city views
views | |
---|---|
Ashburn | 48 |
Johannesburg | 20 |
Hanoi | 9 |
Dublin | 8 |
Des Moines | 6 |
Andover | 4 |
Durban | 4 |
Pretoria | 3 |
Valencia | 3 |
Washington | 3 |
Bengaluru | 2 |
Mountain View | 2 |
Santa Clara | 2 |
Seattle | 2 |
Tzaneen | 2 |
West Palm Beach | 2 |
Athens | 1 |
Bromley | 1 |
Cape Town | 1 |
Changsha | 1 |
Cheyenne | 1 |
Chisinau | 1 |
Chongqing | 1 |
Heidelberg | 1 |
Laiwu | 1 |
Las Vegas | 1 |
New York | 1 |
Nuremberg | 1 |
Scottburgh | 1 |
Secaucus | 1 |
Singapore | 1 |
Stellenbosch | 1 |
Vienna | 1 |